Colcrys for Acute Gout Raleigh NC

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

Quail Corners Animal Hospital
(919) 876-0739
1613 E Millbrook Rd
Raleigh, NC

Data Provided by:
Chiropractic Partners
(919) 787-8883
3700 Six Forks Rd
Raleigh, NC

Data Provided by:
Optimal Wellness Chiro - Dr. Loan Huynh
(919) 576-1423
4008 Barrett Dr., Suite 104
Raleigh, NC

Data Provided by:
Glenn M Davis
(919) 785-1220
2304 Wesvill Court
Raleigh, NC
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Douglas Schmidt DC
(919) 576-1675
5500 McNeely Dr # 103
Raleigh, NC

Data Provided by:
Roger B. Russell
(919) 785-0505
3633 Harden Road
Raleigh, NC
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Team Chiropractic & Sports Medicine - Raleigh
(919) 788-8881
309 W. Millbrook Road, Suite 199
Raleigh, NC

Data Provided by:
Johnson Chiropractic
(919) 876-2212
4412 Falls Of Neuse Rd
Raleigh, NC

Data Provided by:
Avian and Exotic Animal Care
(919) 844-9166
8711 Fidelity Blvd
Raleigh, NC

Data Provided by:
Hidden Valley Animal Hospital
(919) 847-9396
2315 Lynn Rd
Raleigh, NC

Data Provided by:
Data Provided by:

Colcrys for Acute Gout

Provided By:

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

In a news release, the agency said colchicine has been used as a remedy to treat acute gout flares "for many years," despite that it hadn't been FDA approved. The agency said it was in the midst of a program to bring other similarly unapproved products under its regulatory authority.

A dosing study required for approval led the agency to recommend a lower dosing regimen for Colcrys that had been commonly prescribed, the news release said. This was designed to prevent gastrointestinal problems.

The FDA said it was alerting healthcare professionals of the lower dosing schedule and also warning that the drug had the potential for severe interactions with other medications.

FMF, common in Mediterranean nations but less so in the United States, has symptoms including fever, arthritis, and inflammation of the lining of the lungs and abdomen. Colcrys is now the first drug that's been FDA-approved to treat FMF, the agency said.

The drug is produced by Philadelphia-based Mutual Pharmaceutical Company Inc.

More information

The FDA has more about this medication's approval.

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com